Skip to content

ACADIA Pharmaceuticals

US · ACAD #2404 by market cap Listed 1970
17.11 -0.48 -2.73%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About ACADIA Pharmaceuticals

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Founded
1993
CEO
Ms. Catherine Owen Adams
Employees
798
Headquarters
San Diego, California, United States of America
Fiscal year end
12-31
Website
acadia.com

Company profile

Exchange
US
Symbol
ACAD
Market-cap rank
#2404
Listing date
1970-01-01
Market cap
2.96B
Float cap
2.21B
Shares out
172.83M
Float shares
129.32M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ACADIA Pharmaceuticals discussion 0 comments

Add a comment